Pulmonary Hypertension: Symptoms, Causes, and Treatment

Pulmonary hypertension is high blood pressure in the arteries of the lungs, not the systemic blood pressure a home cuff measures on your arm. The two conditions share a name and little else: different arteries, different causes, different tests, and different treatments. This guide covers what pulmonary hypertension actually is, what causes it, how it is diagnosed, and what treatment and outlook genuinely look like today.

What Pulmonary Hypertension Is

Pulmonary hypertension is defined as a resting mean pulmonary artery pressure above 20 mmHg. Right heart catheterization diagnoses it by measuring pressure directly rather than estimating it.

It is not one disease but five, grouped by cause: Pulmonary arterial hypertension, a rare disease of the small lung arteries themselves

• pressure caused by left-sided heart disease, the most common driver overall
• pressure caused by chronic lung disease or low oxygen
• pressure from blood clots that never fully dissolved, called chronic thromboembolic pulmonary hypertension
• a fifth group covering less common or mixed causes

Read More: High Blood Pressure (Hypertension): Symptoms, Causes, Diagnosis, and Treatment

Symptoms

Shortness of breath during activity is almost always the first symptom, and it is also the most commonly dismissed, since it resembles ordinary deconditioning or aging. Fatigue, chest discomfort, a racing heartbeat, and lightheadedness or fainting during exertion follow as the pressure rises. Swelling in the ankles, legs, or abdomen signals that the right side of the heart, which has to push against the elevated pressure, is beginning to struggle.

As the disease advances, symptoms appear with less exertion and eventually at rest: persistent breathlessness, pronounced swelling, and reduced ability to manage daily activities that were previously unaffected. This progression, rather than any single symptom, is usually what prompts a specialist referral.

Causes

The cause depends entirely on which of the five groups applies. Pulmonary arterial hypertension, the rarest and most specific group, can be idiopathic with no identifiable cause, connected to connective tissue disease, congenital heart defects, HIV, or certain appetite suppressants and stimulant drugs, or heritable.

Heritable cases mostly result from mutations in a gene called BMPR2, which accounts for the vast majority of familial cases, though the gene shows incomplete penetrance: not everyone who inherits the mutation develops the disease. Heritable disease is still a small share of pulmonary arterial hypertension overall, most of which is idiopathic or tied to another condition rather than passed down.

The other four groups are more common and generally secondary to an existing condition: left heart failure or valve disease, COPD or interstitial lung disease, sleep apnea, or unresolved blood clots in the lungs. Identifying which group applies changes the entire treatment approach, so the workup is thorough rather than a quick confirmation.

Diagnosis

Diagnosis moves in stages rather than a single test. An echocardiogram is usually first, since it can estimate pulmonary pressure noninvasively and flag the possibility. From there, a ventilation-perfusion scan checks specifically for blood clots as the cause, since that group is treated very differently from the others, sometimes including surgical treatment.

Right heart catheterization confirms the diagnosis and is the only test that measures pulmonary artery pressure directly rather than estimating it. It also determines which of the five groups applies, thereby driving every subsequent treatment decision. Additional testing, including pulmonary function tests, a 6-minute walk test, and blood work, helps establish severity once the diagnosis is confirmed.

Treatment

Treatment splits sharply by group. Pulmonary arterial hypertension is treated with medications developed specifically for it: endothelin receptor antagonists, PDE5 inhibitors, prostacyclin analogs, soluble guanylate cyclase stimulators, and, since 2024, sotatercept (Winrevair), an injectable that targets abnormal cell growth in the vessel walls, often combined rather than used one at a time. Several carry serious precautions: endothelin receptor antagonists and riociguat can cause birth defects and require reliable pregnancy prevention, and PDE5 inhibitors and riociguat must never be combined with nitrates.

For the other groups, treatment focuses on the underlying condition, left heart disease, lung disease, or sleep apnea, since PAH-specific drugs are not proven to help and can sometimes worsen outcomes when the cause lies outside the lung arteries themselves. Left heart disease, the single most common cause overall, is often managed in part with Furosemide, a loop diuretic used to reduce the fluid buildup that drives heart failure symptoms, though the underlying heart condition itself still needs its own dedicated treatment.

Outlook

Pulmonary arterial hypertension remains a serious, progressive condition without a cure, although the outlook has changed substantially. A landmark 1980s registry of untreated patients found a median survival of 2.8 years and a five-year survival of 34 percent. Contemporary registries, reflecting decades of treatment development, report 5-year survival rates as high as 65 percent. Outlook depends on the group, how early it is caught, and how well it responds to treatment.

End-stage disease involves worsening right heart failure: breathlessness at rest, significant fluid retention, and declining ability to perform basic activities. This is a conversation to have directly with a treating specialist who knows the individual case, not one a general article can answer responsibly. The Pulmonary Hypertension Association offers patient and caregiver support groups, an accredited specialist directory, and educational resources specifically for this disease.

Where to Start

Persistent breathlessness during ordinary activity, especially without an obvious explanation like deconditioning or a respiratory infection, is worth raising with a doctor directly rather than waiting to see if it passes. Mention it specifically as unexplained exertional breathlessness, since that phrasing is more likely to prompt the right initial workup than a general complaint of tiredness.

If pulmonary arterial hypertension is diagnosed, care at a specialist center experienced with the disease is strongly associated with better outcomes, since dosing and combining these medications correctly requires specific expertise. A pulmonologist or cardiologist can make that referral.

Read More: High Blood Pressure (Hypertension): Symptoms, Causes, Diagnosis, and Treatment